000 01595 a2200433 4500
005 20250515010632.0
264 0 _c20061211
008 200612s 0 0 eng d
022 _a0021-9150
024 7 _a10.1016/j.atherosclerosis.2005.10.037
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTremblay, André J
245 0 0 _aEffects of fenofibrate on apolipoprotein kinetics in patients with coexisting dysbetalipoproteinemia and heterozygous familial hypercholesterolemia.
_h[electronic resource]
260 _bAtherosclerosis
_cSep 2006
300 _a203-12 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aApolipoprotein A-I
_xblood
650 0 4 _aApolipoprotein B-100
_xblood
650 0 4 _aApolipoprotein B-48
_xblood
650 0 4 _aApolipoproteins
_xblood
650 0 4 _aFenofibrate
_xtherapeutic use
650 0 4 _aHeterozygote
650 0 4 _aHumans
650 0 4 _aHyperlipoproteinemia Type II
_xcomplications
650 0 4 _aHyperlipoproteinemia Type III
_xcomplications
650 0 4 _aHypolipidemic Agents
_xtherapeutic use
650 0 4 _aKinetics
650 0 4 _aMale
650 0 4 _aTriglycerides
_xblood
700 1 _aLamarche, Benoît
700 1 _aRuel, Isabelle L
700 1 _aHogue, Jean-Charles
700 1 _aDeshaies, Yves
700 1 _aGagné, Claude
700 1 _aCouture, Patrick
773 0 _tAtherosclerosis
_gvol. 188
_gno. 1
_gp. 203-12
856 4 0 _uhttps://doi.org/10.1016/j.atherosclerosis.2005.10.037
_zAvailable from publisher's website
999 _c15958418
_d15958418